Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07011628

Transition to Ambulatory Bariatric Surgery (TABS) Trial

This study will compare same day discharge and at least one night stay in the hospital after bariatric surgery. Patients undergoing bariatric surgery will be randomized (i.e. have an equal chance of either plan) to either group. The study's primary outcome is the frequency patients in the study require a visit to the emergency room within 7 days of their surgery.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

25 year–55 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Vanderbilt University Medical Center

Nashville, Tennessee, 37209, United States

About this study

This pragmatic, parallel, randomized, open-label trial aims to determine the safety and feasibility of same day discharge (SDD) for bariatric surgery including sleeve gastrectomy and gastric bypass. Investigators will investigate the frequency of 7-day emergency department visits with SDD after bariatric surgery (Aim 1). In addition, the investigators will compare total 30-day charges between participants who undergo same day discharge versus those receive post-operative hospital admission (Aim 2).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • BMI ≤ 60 kg/m2
  • Primary Sleeve gastrectomy or Gastric Bypass,
  • Undergoing bariatric surgery at sponsor site

Exclusion criteria

  • Type 1 Diabetes
  • Myocardial Infarction
  • Unstable Angina or Heart Failure
  • Prior Stroke
  • Solid organ transplantation
  • Systemic glucocorticoid prior 28 days
  • Severe Obstructive Sleep Apnea
  • Uncontrolled Hypertension (Systolic > 150, Diastolic > 90)
  • Untreated Hyperthyroidism
  • Chronic Kidney Disease (EGFR < 60)
  • Current anticoagulant use,
  • Poorly controlled Type 2 diabetes (Hemoglobin A1c in last 3 months > 8.5%)
  • Chronic opioid use
  • Insulin dependence.
  • Need for extended venous thromboembolic event prophylaxis,
  • > 1 lifetime bariatric surgery (revisional or conversion bariatric surgery)
  • Patient lives > 130 miles from the hospital.
  • Tobacco use in last 12 months
  • Desire to become pregnant or active pregnancy
  • Prisoners
  • Unable or unwilling to follow-up
  • Unable to understand or provide consent

Treatment and study plan

Same day discharge

Other

Patients in the same day discharge arm will be discharged from the hospital within 6 hours of arriving to the recovery unit and without an overnight stay in the hospital.

Primary outcomes

  1. Emergency Department Visits

    Time frame: baseline to seven days

    Number of emergency room visits after surgery

Secondary outcomes

  1. Readmissions to the hospital

    Time frame: baseline to 30 days

    Study personnel will investigate the incidence of readmissions to the hospital in the post-surgical period.

  2. The number of operations or procedures

    Time frame: baseline to 30 days

    Study personnel will compare the frequency of reoperations and procedural interventions after surgery

Study contacts

Contact information is provided by the study sponsor or research team.

Jason Samuels

CONTACT

[email protected]

(615) 322 - 4504 ext. 24504

Sponsors and collaborators

Lead sponsor

Vanderbilt University Medical Center

Other

Registry information

Acronym: TABS

Important dates

Study start
2026
Primary completion
2027
Study completion
2028
First posted
Jun 9, 2025
Registry last updated
May 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.